SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-140559
Filing Date
2021-04-29
Accepted
2021-04-29 16:30:57
Documents
10
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d112788ddef14a.htm DEF 14A 420116
2 GRAPHIC g1127881.jpg GRAPHIC 2375
3 GRAPHIC g1127882.jpg GRAPHIC 1397
4 GRAPHIC g1127883.jpg GRAPHIC 1089
5 GRAPHIC g1127884.jpg GRAPHIC 1640
6 GRAPHIC g1127885.jpg GRAPHIC 1583
7 GRAPHIC g1127886.jpg GRAPHIC 1900
8 GRAPHIC g1127887.jpg GRAPHIC 1388
9 GRAPHIC g112788g01z61.jpg GRAPHIC 34002
10 GRAPHIC g112788g14h12.jpg GRAPHIC 43016
  Complete submission text file 0001193125-21-140559.txt   544351
Mailing Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037
Business Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39321 | Film No.: 21871181
SIC: 2834 Pharmaceutical Preparations